Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals
20001.4k citationsHarry M. Olson, Graham R. Betton et al.Regulatory Toxicology and Pharmacologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Harry M. Olson
Since
Specialization
Citations
This map shows the geographic impact of Harry M. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry M. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry M. Olson more than expected).
This network shows the impact of papers produced by Harry M. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry M. Olson. The network helps show where Harry M. Olson may publish in the future.
Co-authorship network of co-authors of Harry M. Olson
This figure shows the co-authorship network connecting the top 25 collaborators of Harry M. Olson.
A scholar is included among the top collaborators of Harry M. Olson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Harry M. Olson. Harry M. Olson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Olson, Harry M., Graham R. Betton, Denise E. Robinson, et al.. (2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology. 32(1). 56–67.1417 indexed citations breakdown →
Hunt, Steven C., et al.. (1991). Effects of long term 2% fish oil supplements on tissue fatty acids, phospholipids, cholesterol, and arterial histology in Japanese quail (Coturnix coturnix japonica).. PubMed. 18(6). 291–314.7 indexed citations
7.
Olson, Harry M., et al.. (1980). Alterations of lactate dehydrogenase isoenzymes with subacute adriamycin toxicity.. PubMed. 63(11-12). 2057–9.8 indexed citations
8.
Olson, Harry M. & Charles C. Capen. (1978). Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(6). 1561–7.4 indexed citations
Olson, Harry M. & C. C. Capen. (1977). Virus-induced animal model of osteosarcoma in the rat: Morphologic and biochemical studies.. PubMed. 86(2). 437–58.16 indexed citations
Olson, Harry M., David M. Young, David J. Prieur, A Leroy, & Reginald L. Reagan. (1974). Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.. PubMed. 77(3). 439–54.189 indexed citations
15.
Prieur, David J., Harry M. Olson, & David M. Young. (1974). Lysozyme deficiency-an inherited disorder of rabbits.. PubMed. 77(2). 283–98.27 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.